Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0880
J

Insulin Pen Shared Between Residents by LPN

Unity, New Hampshire Survey Completed on 06-06-2025

Penalty

Fine: $16,153
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A Licensed Practical Nurse (LPN) administered insulin to one resident using another resident's previously used insulin pen, resulting in potential exposure to bloodborne pathogens. The incident occurred when the LPN used the insulin pen belonging to one resident to administer a dose to a different resident after the latter had run out of their own insulin. This action was confirmed through staff interviews and review of the electronic medication administration records, which showed that both residents had active physician orders for insulin and that the medication was documented as given on the same day. Manufacturer instructions for the insulin pen and facility policy both explicitly state that insulin pens are for single-patient use and must not be shared between residents, even with a new needle, due to the risk of transmitting infections. The Centers for Disease Control and Prevention (CDC) also provides guidance that insulin pens should never be used for more than one patient because blood may be present in the pen after use. The facility's policy further reinforces that medications supplied for one resident are never to be administered to another resident. Despite these clear guidelines, the LPN administered insulin in a manner that violated both manufacturer and facility protocols.

An unhandled error has occurred. Reload 🗙